XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Total United Natural Foods, Inc. Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance (in shares) at Jul. 30, 2022     58.9 0.6        
Beginning balance at Jul. 30, 2022 $ 1,792 $ 1,791 $ 1 $ (24) $ 608 $ (20) $ 1,226 $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     2.0          
Restricted stock vestings (39) (39)     (39)      
Share-based compensation 23 23     23      
Repurchases of common stock (in shares)       0.7        
Repurchases of common stock (29) (29)   $ (29)        
Other comprehensive income (loss) 11 11       11    
Distributions to noncontrolling interests (2)             (2)
Net (loss) income 89 85         85 4
Ending balance (in shares) at Jan. 28, 2023     60.9 1.3        
Ending balance at Jan. 28, 2023 1,845 1,842 $ 1 $ (53) 592 (9) 1,311 3
Beginning balance (in shares) at Oct. 29, 2022     60.9 1.0        
Beginning balance at Oct. 29, 2022 1,835 1,835 $ 1 $ (36) 583 (5) 1,292 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (2) (2)     (2)      
Share-based compensation 11 11     11      
Repurchases of common stock (in shares)       0.3        
Repurchases of common stock (17) (17)   $ (17)        
Other comprehensive income (loss) (4) (4)       (4)    
Net (loss) income 22 19         19 3
Ending balance (in shares) at Jan. 28, 2023     60.9 1.3        
Ending balance at Jan. 28, 2023 $ 1,845 1,842 $ 1 $ (53) 592 (9) 1,311 3
Beginning balance (in shares) at Jul. 29, 2023 58.5   61.0 2.5        
Beginning balance at Jul. 29, 2023 $ 1,744 1,743 $ 1 $ (86) 606 (28) 1,250 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     0.9          
Restricted stock vestings (6) (6)     (6)      
Share-based compensation 16 16     16      
Other comprehensive income (loss) (7) (7)       (7)    
Distributions to noncontrolling interests (2)             (2)
Net (loss) income $ (53) (54)         (54) 1
Ending balance (in shares) at Jan. 27, 2024 59.4   61.9 2.5        
Ending balance at Jan. 27, 2024 $ 1,692 1,692 $ 1 $ (86) 616 (35) 1,196 0
Beginning balance (in shares) at Oct. 28, 2023     61.9 2.5        
Beginning balance at Oct. 28, 2023 1,699 1,699 $ 1 $ (86) 606 (33) 1,211 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 10 10     10      
Other comprehensive income (loss) (2) (2)       (2)    
Distributions to noncontrolling interests (1)             (1)
Net (loss) income $ (14) (15)         (15) 1
Ending balance (in shares) at Jan. 27, 2024 59.4   61.9 2.5        
Ending balance at Jan. 27, 2024 $ 1,692 $ 1,692 $ 1 $ (86) $ 616 $ (35) $ 1,196 $ 0